AEON Biopharma Inc.

AEON | AMEX

Price Alert Chart Builder DCF Calculator

$0.48

-$0.02 (-4.52%)

At close: Jul 10, 2026, 3:58 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-4.52%

(1D)

Rating

Updated: May 12, 2026

34.5

Fundamentals Weak

Market Sentiment Neutral

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $5.72M

1D Range

0.48 0.52

52W Range

0.48 1.45

Valuation (TTM)

PE -0.10

PB -0.34

EV/EBITDA -0.09

Valuation (NTM)

Forward PE N/A

Forward PEG N/A

Price Target N/A

Cash Flow

FCF Yield -210.6%

SBC Adj. FCF Yield -307.2%

SBC Impact -45.9%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | -20.0%

Dil EPS 3Y | 5Y 28.5% | 19.9%

FCF 3Y | 5Y 17.3% | -16.6%

Returns

ROA -696.5%

ROE 223.7%

ROIC -823.8%

Financial Health

Net Cash

$4.7M

Current Ratio 0.99

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key invest...

Sector Healthcare

Industry Biotechnology

Employees 5

IPO Date Jul 23, 2023

Website www.aeonbiopharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞